Product
Pamrevlumab + Gemcitabine + Nab-paclitaxel
Aliases
5-Fluracil, Abraxane, Camptosar, Efudex, Eloxitan (4 other aliases)
Name
Camptosar
INN Name
Fluorouracil
FDA Approved
Yes
1 clinical trial
2 organizations
1 drug
1 indication
2 documents
Indication
Pancreatic CancerDrug
mFOLFOXIRIClinical trial
A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in Combination With Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX as Neoadjuvant Treatment in Patients With Locally Advanced, Unresectable Pancreatic CancerStatus: Active (not recruiting), Estimated PCD: 2024-04-30
Document
DailyMed Label: CamptosarOrganization
Pharmacia & Upjohn Company LLCDocument
DailyMed Label: EfudexOrganization
Bausch Health US, LLC